| Erin E Shaffer, DO | |
|
991 Route 19 N Ste B, Waterford, PA 16441-9739 | |
| (814) 877-8790 | |
| (814) 796-4238 |
| Full Name | Erin E Shaffer |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 991 Route 19 N Ste B, Waterford, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457762122 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OT015767 (Pennsylvania) | Secondary |
| 207Q00000X | Family Medicine | OS017824 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Hamot Hospital | Erie, PA | Hospital |
| Saint Vincent Hospital | Erie, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Health Services Inc | 4880593722 | 484 |
News Archive
Researchers compared the nasal microbiome of coronavirus disease 2019 (COVID-19) patients, healthy individuals, and healthcare workers. These studies indicated an increase in the pathogen Pseudomonas aeruginosa present in the nasal microbiome of COVID-19 patients, which may be responsible for other secondary infections.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of data in two poster presentations at the 22nd EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics," held in Berlin, Germany, November 16-19.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced additional details of its new Phase 2 clinical trial (the 2015 WF10 Trial) to assess WF10 for the treatment of allergic rhinitis.
Despite rapid strides in minimally invasive surgical techniques - most notably, laparoscopy - traditional open surgery remains the most common surgical option across the United States for people with diseases of the rectum and colon.
A summit of more than 60 high-level policymakers, leaders and health experts have adopted a global plan aimed at tackling the growing cancer crisis in developing countries.
› Verified 2 days ago
| Entity Name | Regional Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174520654 PECOS PAC ID: 4880593722 Enrollment ID: O20040108000694 |
News Archive
Researchers compared the nasal microbiome of coronavirus disease 2019 (COVID-19) patients, healthy individuals, and healthcare workers. These studies indicated an increase in the pathogen Pseudomonas aeruginosa present in the nasal microbiome of COVID-19 patients, which may be responsible for other secondary infections.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of data in two poster presentations at the 22nd EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics," held in Berlin, Germany, November 16-19.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced additional details of its new Phase 2 clinical trial (the 2015 WF10 Trial) to assess WF10 for the treatment of allergic rhinitis.
Despite rapid strides in minimally invasive surgical techniques - most notably, laparoscopy - traditional open surgery remains the most common surgical option across the United States for people with diseases of the rectum and colon.
A summit of more than 60 high-level policymakers, leaders and health experts have adopted a global plan aimed at tackling the growing cancer crisis in developing countries.
› Verified 2 days ago
| Entity Name | Washington Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316917669 PECOS PAC ID: 6103719562 Enrollment ID: O20040209000011 |
News Archive
Researchers compared the nasal microbiome of coronavirus disease 2019 (COVID-19) patients, healthy individuals, and healthcare workers. These studies indicated an increase in the pathogen Pseudomonas aeruginosa present in the nasal microbiome of COVID-19 patients, which may be responsible for other secondary infections.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of data in two poster presentations at the 22nd EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics," held in Berlin, Germany, November 16-19.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced additional details of its new Phase 2 clinical trial (the 2015 WF10 Trial) to assess WF10 for the treatment of allergic rhinitis.
Despite rapid strides in minimally invasive surgical techniques - most notably, laparoscopy - traditional open surgery remains the most common surgical option across the United States for people with diseases of the rectum and colon.
A summit of more than 60 high-level policymakers, leaders and health experts have adopted a global plan aimed at tackling the growing cancer crisis in developing countries.
› Verified 2 days ago
| Entity Name | Washington Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1922077205 PECOS PAC ID: 0446159313 Enrollment ID: O20050420000827 |
News Archive
Researchers compared the nasal microbiome of coronavirus disease 2019 (COVID-19) patients, healthy individuals, and healthcare workers. These studies indicated an increase in the pathogen Pseudomonas aeruginosa present in the nasal microbiome of COVID-19 patients, which may be responsible for other secondary infections.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of data in two poster presentations at the 22nd EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics," held in Berlin, Germany, November 16-19.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced additional details of its new Phase 2 clinical trial (the 2015 WF10 Trial) to assess WF10 for the treatment of allergic rhinitis.
Despite rapid strides in minimally invasive surgical techniques - most notably, laparoscopy - traditional open surgery remains the most common surgical option across the United States for people with diseases of the rectum and colon.
A summit of more than 60 high-level policymakers, leaders and health experts have adopted a global plan aimed at tackling the growing cancer crisis in developing countries.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin E Shaffer, DO 991 Route 19 N Ste B, Waterford, PA 16441-9739 Ph: (814) 877-8790 | Erin E Shaffer, DO 991 Route 19 N Ste B, Waterford, PA 16441-9739 Ph: (814) 877-8790 |
News Archive
Researchers compared the nasal microbiome of coronavirus disease 2019 (COVID-19) patients, healthy individuals, and healthcare workers. These studies indicated an increase in the pathogen Pseudomonas aeruginosa present in the nasal microbiome of COVID-19 patients, which may be responsible for other secondary infections.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of data in two poster presentations at the 22nd EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics," held in Berlin, Germany, November 16-19.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced additional details of its new Phase 2 clinical trial (the 2015 WF10 Trial) to assess WF10 for the treatment of allergic rhinitis.
Despite rapid strides in minimally invasive surgical techniques - most notably, laparoscopy - traditional open surgery remains the most common surgical option across the United States for people with diseases of the rectum and colon.
A summit of more than 60 high-level policymakers, leaders and health experts have adopted a global plan aimed at tackling the growing cancer crisis in developing countries.
› Verified 2 days ago
Craig Douglas Caldwell, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 991 Route 19 N Ste B, Waterford, PA 16441 Phone: 814-796-2553 Fax: 814-796-4238 | |
Micalyn D Baney, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 220 E 3rd St, Waterford, PA 16441 Phone: 814-796-6791 Fax: 814-796-6517 | |
Nathan M Moore, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 991 Route 19 N Ste B, Waterford, PA 16441 Phone: 814-877-8790 Fax: 814-796-4238 | |
Dr. Brian Michael Wojtkielewicz, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 991 Route 19 N Ste B, Waterford, PA 16441 Phone: 814-877-8790 Fax: 814-796-4238 | |
Carl E Eby, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 991 Route 19 N Ste B, Waterford, PA 16441 Phone: 814-877-8790 Fax: 814-796-4238 |